{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T03:55:28Z","timestamp":1783396528359,"version":"3.54.6"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:00:00Z","timestamp":1691020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:00:00Z","timestamp":1691020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s00204-023-03563-8","type":"journal-article","created":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T16:01:42Z","timestamp":1691078502000},"page":"2575-2585","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Neonatal opioid toxicity: opioid withdrawal (abstinence) syndrome with emphasis on pharmacogenomics and respiratory depression"],"prefix":"10.1007","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9401-4865","authenticated-orcid":false,"given":"Brian A.","family":"Baldo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,3]]},"reference":[{"key":"3563_CR1","unstructured":"Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) https:\/\/heal.nih.gov\/research\/infants-and-children\/act-now Accessed 29 April 2023"},{"key":"3563_CR2","volume-title":"Neonatal abstinence syndrome","author":"S Anbalagan","year":"2023","unstructured":"Anbalagan S, Mendez MD (2023) Neonatal abstinence syndrome. StatPearls Publishing, Treasure Island. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK551498\/. Accessed 30 April 2023"},{"key":"3563_CR3","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1007\/s00204-021-03068-2","volume":"95","author":"BA Baldo","year":"2021","unstructured":"Baldo BA (2021) Toxicities of opioid analgesics: respiratory depression, histamine release, hemodynamic changes, hypersensitivity, serotonin toxicity. Arch Toxicol 95:2627\u20132642. https:\/\/doi.org\/10.1007\/s00204-021-03068-2","journal-title":"Arch Toxicol"},{"key":"3563_CR4","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/978-3-030-51740-3","volume-title":"Drug allergy: clinical aspects, diagnosis, mechanisms, structure-activity relationships","author":"BA Baldo","year":"2021","unstructured":"Baldo BA, Pham NH (2021) Drug allergy: clinical aspects, diagnosis, mechanisms, structure-activity relationships, 2nd edn. Springer Nature, Cham, pp 411\u2013438. https:\/\/doi.org\/10.1007\/978-3-030-51740-3","edition":"2"},{"key":"3563_CR5","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1007\/s00204-022-03300-7","volume":"96","author":"BA Baldo","year":"2022","unstructured":"Baldo BA, Rose MA (2022) Mechanisms of opioid-induced respiratory depression. Arch Toxicol 96:2247\u20132260. https:\/\/doi.org\/10.1007\/s00204-022-03300-7","journal-title":"Arch Toxicol"},{"key":"3563_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/ajad.12172","volume":"24","author":"IE Bauer","year":"2015","unstructured":"Bauer IE, Soares JC, Nielsen DA (2015) The role of opioidergic genes in the treatment outcome of drug addiction pharmacotherapy: a systematic review. Am J Addict 24:15\u201323. https:\/\/doi.org\/10.1111\/ajad.12172","journal-title":"Am J Addict"},{"key":"3563_CR7","doi-asserted-by":"publisher","first-page":"1109754","DOI":"10.3389\/fphys.2023.1109754","volume":"14","author":"SA Beyeler","year":"2023","unstructured":"Beyeler SA, Naidoo R, Morrison NR et al (2023) Maternal opioids age-dependently impair neonatal respiratory control networks. Front Physiol 14:1109754. https:\/\/doi.org\/10.3389\/fphys.2023.1109754","journal-title":"Front Physiol"},{"key":"3563_CR8","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/jnr.24642","volume":"100","author":"T Boggess","year":"2022","unstructured":"Boggess T, Risher WC (2022) Clinical and basic research investigations into the long-term effects of prenatal opioid exposure on brain development. J Neurosci Res 100:396\u2013409. https:\/\/doi.org\/10.1002\/jnr.24642","journal-title":"J Neurosci Res"},{"key":"3563_CR9","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1111\/febs.15496","volume":"288","author":"SA Buck","year":"2021","unstructured":"Buck SA, Torregrossa MM, Logan RW et al (2021) Roles of dopamine and glutamate co-release in the nucleus accumbens in mediating the actions of drugs of abuse. FEBS J 288:1462\u20131474. https:\/\/doi.org\/10.1111\/febs.15496","journal-title":"FEBS J"},{"key":"3563_CR10","unstructured":"CDC for disease control and prevention. NVSS vital statistics rapid release overdose death counts. Update 2\/16\/2022. https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drugoverdose-data.htm. Accessed June 1, 2023"},{"key":"3563_CR11","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ynstr.2018.08.005","volume":"9","author":"E Conradt","year":"2018","unstructured":"Conradt E, Crowell SE, Lester BM (2018) Early life stress and environmental influences on the neurodevelopment of children with prenatal opioid exposure. Neurobiol Stress 9:48\u201354. https:\/\/doi.org\/10.1016\/j.ynstr.2018.08.005","journal-title":"Neurobiol Stress"},{"key":"3563_CR12","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/pds.4366","volume":"27","author":"DT Coyle","year":"2018","unstructured":"Coyle DT, Pratt CY, Ocran-Appiah J et al (2018) Opioid analgesic dose and the risk of misuse, overdose, and death: a narrative review. Pharmacoepidemiol Drug Saf 27:464\u2013472. https:\/\/doi.org\/10.1002\/pds.4366","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"3563_CR13","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.neuron.2016.07.003","volume":"91","author":"Y Cui","year":"2016","unstructured":"Cui Y, Kam K, Sherman D et al (2016) Defning preB\u00f6tzinger complex rhythm- and pattern-generating neural microcircuits in vivo. Neuron 91:602\u2013614. https:\/\/doi.org\/10.1016\/j.neuron.2016.07.003","journal-title":"Neuron"},{"key":"3563_CR14","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/JPN.0000000000000056","volume":"28","author":"KC D\u2019Apolito","year":"2014","unstructured":"D\u2019Apolito KC (2014) Assessing neonates for neonatal abstinence. J Perinat Neonat Nurs 28:220\u2013231. https:\/\/doi.org\/10.1097\/JPN.0000000000000056","journal-title":"J Perinat Neonat Nurs"},{"key":"3563_CR15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41583-018-0003-6","volume":"19","author":"CA Del Negro","year":"2018","unstructured":"Del Negro CA, Funk GD, Feldman JL (2018) Breathing matters. Nat Rev Neurosci 19:351\u2013367. https:\/\/doi.org\/10.1038\/s41583-018-0003-6","journal-title":"Nat Rev Neurosci"},{"key":"3563_CR16","doi-asserted-by":"publisher","first-page":"e86114","DOI":"10.1371\/journal.pone.0086114","volume":"9","author":"BB Dennis","year":"2014","unstructured":"Dennis BB, Bawor M, Thabane L et al (2014) Impact of ABCB1 and CYP2B6 genetic polymorphisms on methadone metabolism, dose and treatment response in patients with opioid addiction: A systematic review and meta-analysis. PLoS ONE. 9:e86114. https:\/\/doi.org\/10.1371\/journal.pone.0086114","journal-title":"PLoS ONE."},{"key":"3563_CR17","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s41372-021-01206-3","volume":"42","author":"LA Devlin","year":"2022","unstructured":"Devlin LA, Young LW, Kraft WK et al (2022) Neonatal opioid withdrawal syndrome: a review of the science and a look toward the use of buprenorphine for affected infants. J Perinatol 42:300\u2013306. https:\/\/doi.org\/10.1038\/s41372-021-01206-3","journal-title":"J Perinatol"},{"key":"3563_CR18","doi-asserted-by":"publisher","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","volume":"85","author":"G Di Chiara","year":"1988","unstructured":"Di Chiara G, Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85:5274\u20135278. https:\/\/doi.org\/10.1073\/pnas.85.14.5274","journal-title":"Proc Natl Acad Sci USA"},{"key":"3563_CR19","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrn.2017.107","volume":"18","author":"E Di Lullo","year":"2017","unstructured":"Di Lullo E, Kriegstein AR (2017) The use of brain organoids to investigate neural development and disease. Nat Rev Neurosci 18:573\u2013584. https:\/\/doi.org\/10.1038\/nrn.2017.107","journal-title":"Nat Rev Neurosci"},{"key":"3563_CR20","first-page":"936","volume":"81","author":"TM Doberczak","year":"1993","unstructured":"Doberczak TM, Kandall SR, Friedmann P (1993) Relationship between maternal methadone dosage, maternal-neonatal methadone levels, and neonatal withdrawal. Obstet Gynecol 81:936\u2013940","journal-title":"Obstet Gynecol"},{"key":"3563_CR22","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3389\/fnins.2015.00404","volume":"9","author":"MS D'Souza","year":"2015","unstructured":"D\u2019Souza MS (2015) Glutamatergic transmission in drug reward: implications for drug addiction. Front Neurosci 9:404. https:\/\/doi.org\/10.3389\/fnins.2015.00404","journal-title":"Front Neurosci"},{"key":"3563_CR23","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.annepidem.2013.05.017","volume":"23","author":"RA Epstein","year":"2013","unstructured":"Epstein RA, Bobo WV, Martin PR et al (2013) Increasing pregnancy-related use of prescribed opioid analgesics. Ann Epidemiol 23:498\u2013503. https:\/\/doi.org\/10.1016\/j.annepidem.2013.05.017","journal-title":"Ann Epidemiol"},{"key":"3563_CR24","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1002\/PDS.4848","volume":"28","author":"S F\u00e4ltmarch","year":"2019","unstructured":"F\u00e4ltmarch S, Perttil\u00e4 I, Tuomi U et al (2019) Use of opioids during pregnancy and effects of pregnancy outcomes. Pharmacoepidemiol Drug Saf 28:1239\u20131245. https:\/\/doi.org\/10.1002\/PDS.4848","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"3563_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2174\/157015908784533842","volume":"6","author":"WO Farid","year":"2008","unstructured":"Farid WO, Dunlop SA, Tait RJ et al (2008) The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: Review of human and animal data. Curr Neuropharmacol 6:125\u2013150. https:\/\/doi.org\/10.2174\/157015908784533842","journal-title":"Curr Neuropharmacol"},{"key":"3563_CR26","unstructured":"FDA news release: FDA announces safety labeling changes and post-market study requirements for extended-release and long-acting opioid analgesics\u2014new boxed warning to include neonatal opioid withdrawal syndrome. 2013 http:\/\/wayback.archiveit.org\/7993\/20170112130229\/http:\/www.fda.gov\/NewsEvents\/ Newsroom\/PressAnnouncements\/ucm367726.htm. Accessed June 1, 2023"},{"key":"3563_CR27","unstructured":"FDA prescribing information, morphine sulfate (2016). Adverse reactions. Available from: https:\/\/www.accessdata.fda.gov\/drugs atfda_docs\/label\/2017\/208603s000lbl.pdf. Accessed 20 May 2023"},{"key":"3563_CR28","first-page":"19","volume":"12","author":"LP Finnegan","year":"1975","unstructured":"Finnegan LP, Kron RE, Connaughton JF et al (1975) Assessment and treatment of abstinence in the infant of the drug-dependent mother. Int J Clin Pharmacol Biopharm 12:19\u201332","journal-title":"Int J Clin Pharmacol Biopharm"},{"key":"3563_CR29","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3389\/fphys.2017.00571","volume":"8","author":"AJ Garcia","year":"2017","unstructured":"Garcia AJ, Dashevskiy T, Khuu MA et al (2017) (2017) Chronic intermittent hypoxia differentially impacts different states of inspiratory activity at the level of the preB\u00f6tzinger complex. Front Physiol 8:571. https:\/\/doi.org\/10.3389\/fphys.2017.00571","journal-title":"Front Physiol"},{"key":"3563_CR30","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/nrg1635","volume":"6","author":"D Goldman","year":"2005","unstructured":"Goldman D, Oroszi G, Ducci F (2005) The genetics of addictions: uncovering the genes. Nat Rev Genet. 6:521\u2013532. https:\/\/doi.org\/10.1038\/nrg1635","journal-title":"Nat Rev Genet."},{"key":"3563_CR31","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.expneurol.2016.03.020","volume":"287","author":"B Gourevitch","year":"2017","unstructured":"Gourevitch B, Cai J, Mellen N (2017) Cellular and network-level adaptations to in utero methadone exposure along the ventral respiratory column in the neonate rat. Exper Neurol 287:288\u2013297. https:\/\/doi.org\/10.1016\/j.expneurol.2016.03.020","journal-title":"Exper Neurol"},{"key":"3563_CR32","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1126\/science.286.5444.1566","volume":"286","author":"PA Gray","year":"1999","unstructured":"Gray PA, Rekling JC, Bocchiaro CM et al (1999) Modulation of respiratory frequency by peptidergic input to rhythmogenic neurons in the preB\u00f6tzinger complex. Science 286:1566\u20131568. https:\/\/doi.org\/10.1126\/science.286.5444.1566","journal-title":"Science"},{"key":"3563_CR33","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/bjaceaccp\/mku013","volume":"15","author":"SK Griffiths","year":"2015","unstructured":"Griffiths SK, Campbell JP (2015) Placental structure, function and drug transfer. Cont Edu Anaesth Crit Care Pain. 15:84\u201389. https:\/\/doi.org\/10.1093\/bjaceaccp\/mku013","journal-title":"Cont Edu Anaesth Crit Care Pain."},{"key":"3563_CR34","doi-asserted-by":"publisher","first-page":"e527","DOI":"10.1542\/peds.2013-4036","volume":"134","author":"ES Hall","year":"2014","unstructured":"Hall ES, Wexeblatt SL, Crowley M et al (2014) A multicenter cohort study of treatments and hospital outcomes in neonatal abstinence syndrome. Pediatrics 134:e527\u2013e534. https:\/\/doi.org\/10.1542\/peds.2013-4036","journal-title":"Pediatrics"},{"issue":"5","key":"3563_CR35","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3389\/fped.2017.00294","volume":"23","author":"KF Hauser","year":"2018","unstructured":"Hauser KF, Knapp PE (2018) Opiate drugs with abuse liability hijack the endogenous opioid system to disrupt neuronal and glial maturation in the central nervous system. Front Pediatr 23(5):294. https:\/\/doi.org\/10.3389\/fped.2017.00294","journal-title":"Front Pediatr"},{"key":"3563_CR36","doi-asserted-by":"publisher","first-page":"a039602","DOI":"10.1101\/cshperspect.a039602","volume":"11","author":"JA Heinsbroek","year":"2021","unstructured":"Heinsbroek JA, De Vries TJ, Peters J (2021) Glutamatergic systems and memory mechanisms underlying opioid addiction. Cold Spring Harb Perspect Med. 11:a039602. https:\/\/doi.org\/10.1101\/cshperspect.a039602","journal-title":"Cold Spring Harb Perspect Med."},{"key":"3563_CR37","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1001\/jama.2020.24991","volume":"325","author":"AH Hirai","year":"2021","unstructured":"Hirai AH, Ko JY, Owens PL et al (2021) Neonatal abstinence syndrome and maternal opioid-related diagnoses in the US, 2000\u20132017. JAMA 325:146\u2013155. https:\/\/doi.org\/10.1001\/jama.2020.24991","journal-title":"JAMA"},{"key":"3563_CR38","doi-asserted-by":"publisher","first-page":"604593","DOI":"10.3389\/fphys.2021.604593","volume":"12","author":"AD Hocker","year":"2021","unstructured":"Hocker AD, Morrison NR, Selby ML et al (2021) Maternal methadone destabilizes neonatal breathing and desensitizes neonates to opioid-induced respiratory frequency depression. Front Physiol. 12:604593. https:\/\/doi.org\/10.3389\/fphys.2021.604593","journal-title":"Front Physiol."},{"key":"3563_CR39","doi-asserted-by":"publisher","first-page":"e540","DOI":"10.1542\/peds.2011-3212","volume":"129","author":"ML Hudak","year":"2012","unstructured":"Hudak ML, Tan RC (2012) Neonatal drug withdrawal. Pediatrics 129:e540\u2013e560. https:\/\/doi.org\/10.1542\/peds.2011-3212","journal-title":"Pediatrics"},{"key":"3563_CR40","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/jnr.24811","volume":"100","author":"L Isaac","year":"2022","unstructured":"Isaac L, van den Hoogen NJ, Habib S et al (2022) Maternal and iatrogenic neonatal opioid withdrawal syndrome: differences and similarities in recognition, management, and consequences. J Neurosci Res 100:373\u2013395. https:\/\/doi.org\/10.1002\/jnr.24811","journal-title":"J Neurosci Res"},{"key":"3563_CR94","unstructured":"Jansson LM (2023) UpToDate Prenatal substance exposure and neonatal abstinence syndrome (NAS): Management and outcomes. https:\/\/www.uptodate.com\/contents\/prenatal-substance-exposure-and-neonatal-abstinence-syndrome-nas-management-and-outcomes Accessed June 30, 2023"},{"key":"3563_CR41","doi-asserted-by":"publisher","first-page":"47","DOI":"10.5055\/jom.2009.0006","volume":"5","author":"LM Jansson","year":"2009","unstructured":"Jansson LM, Velez M, Harrow C (2009) The opioid-exposed newborn: assessment and pharmacologic management. J Opioid Manag 5:47\u201355","journal-title":"J Opioid Manag"},{"key":"3563_CR42","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1300\/J069v18n04_05","volume":"18","author":"MA Jarvis","year":"1999","unstructured":"Jarvis MA, Wu-Pong S, Kniseley JS et al (1999) Alterations in methadone metabolism during late pregnancy. J Addict Dis 18:51\u201361. https:\/\/doi.org\/10.1300\/J069v18n04_05","journal-title":"J Addict Dis"},{"key":"3563_CR43","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1177\/0033354920902476","volume":"135","author":"SM Jilani","year":"2020","unstructured":"Jilani SM, Giroir BP (2020) Neonatal abstinence syndrome: leveraging health information technology to develop a data-driven national policy approach. Public Health Rep 135:173\u2013176. https:\/\/doi.org\/10.1177\/0033354920902476","journal-title":"Public Health Rep"},{"key":"3563_CR44","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1038\/s41372-020-00893-8","volume":"41","author":"SM Jilani","year":"2021","unstructured":"Jilani SM, Jordan CJ, Jansson LM et al (2021) Definitions of neonatal abstinence syndrome in clinical studies of mother and infants: an expert literature review. J Perinatol 41:1364\u20131371. https:\/\/doi.org\/10.1038\/s41372-020-00893-8","journal-title":"J Perinatol"},{"key":"3563_CR45","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jpeds.2021.12.021","volume":"243","author":"SM Jilani","year":"2022","unstructured":"Jilani SM, Jones HE, Grossman M et al (2022) Standardizing the clinical definition of opioid withdrawal in the neonate. J Pediatr 243:33\u201339. https:\/\/doi.org\/10.1016\/j.jpeds.2021.12.021","journal-title":"J Pediatr"},{"key":"3563_CR46","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","volume":"363","author":"HE Jones","year":"2010","unstructured":"Jones HE, Kaltenbach K, Heil SH et al (2010a) Neonatal abstinence syndrome after methadone or buprenorphine exposure. New Engl J Med 363:2320\u20132331. https:\/\/doi.org\/10.1056\/NEJMoa1005359","journal-title":"New Engl J Med"},{"key":"3563_CR47","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.3109\/10826084.2010.484474","volume":"45","author":"HE Jones","year":"2010","unstructured":"Jones HE, O\u2019Grady KE, Johnson RE et al (2010b) Infant neurobehavior following prenatal exposure to methadone or buprenorphine: results from the neonatal intensive care unit network neurobehavioral scale. Subst Use Misuse 45:2244\u20132257. https:\/\/doi.org\/10.3109\/10826084.2010.484474","journal-title":"Subst Use Misuse"},{"key":"3563_CR48","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ntt.2013.05.003","volume":"39","author":"HE Jones","year":"2013","unstructured":"Jones HE, Jansson LM, O\u2019Grady KE et al (2013) The relationship between maternal methadone dose at delivery and neonatal outcome: methodological and design considerations. Neurotoxicol Teratol 39:110\u2013115. https:\/\/doi.org\/10.1016\/j.ntt.2013.05.003","journal-title":"Neurotoxicol Teratol"},{"issue":"Suppl 1","key":"3563_CR49","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1360-0443.2012.04038.x","volume":"107","author":"K Kaltenbach","year":"2012","unstructured":"Kaltenbach K, Holbrook AM, Coyle MG et al (2012) Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication. Addiction 107(Suppl 1):45\u201352. https:\/\/doi.org\/10.1111\/j.1360-0443.2012.04038.x","journal-title":"Addiction"},{"key":"3563_CR50","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1001\/archpsyc.57.3.261","volume":"57","author":"KS Kendler","year":"2000","unstructured":"Kendler KS, Karkowski LM, Neale MC et al (2000) (2000) Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins. Arch Gen Psychiatry 57:261\u2013269. https:\/\/doi.org\/10.1001\/archpsyc.57.3.261","journal-title":"Arch Gen Psychiatry"},{"key":"3563_CR51","doi-asserted-by":"publisher","first-page":"897","DOI":"10.15585\/mmwr.mm6928a1","volume":"69","author":"JY Ko","year":"2020","unstructured":"Ko JY, D\u2019Angelo DV, Haight SC et al (2020) Vital signs: prescription opioid pain reliever use during pregnancy \u2013 34 US jurisdictions. Morb Mortal Wkly Rep 69:897\u2013903","journal-title":"Morb Mortal Wkly Rep"},{"key":"3563_CR52","doi-asserted-by":"publisher","first-page":"e547","DOI":"10.1542\/peds.2013-3524","volume":"134","author":"P Kocherlakota","year":"2014","unstructured":"Kocherlakota P (2014) Neonatal abstinence syndrome. Pediatrics 134:e547\u2013e561. https:\/\/doi.org\/10.1542\/peds.2013-3524","journal-title":"Pediatrics"},{"key":"3563_CR53","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1053\/j.semperi.2015.12.007","volume":"40","author":"WK Kraft","year":"2016","unstructured":"Kraft WK, Stover MW, Davis JM (2016) Neonatal abstinence syndrome: pharmacologic strategies for the mother and infant. Semin Perinatol 40:203\u2013212. https:\/\/doi.org\/10.1053\/j.semperi.2015.12.007","journal-title":"Semin Perinatol"},{"key":"3563_CR54","doi-asserted-by":"publisher","first-page":"752854","DOI":"10.3389\/fped.2021.752854","volume":"9","author":"A Kushnir","year":"2022","unstructured":"Kushnir A, Garretson C, Mariappan M et al (2022) Use of phenobarbital to treat neonatal abstinence syndrome from exposure to single vs. multiple substances. Front Pediatr. 9:752854. https:\/\/doi.org\/10.3389\/fped.2021.752854","journal-title":"Front Pediatr."},{"key":"3563_CR55","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1097\/ALN.0000000000000564","volume":"122","author":"LA Lee","year":"2015","unstructured":"Lee LA, Caplan RA, Stephens LS et al (2015) Postoperative opioid induced respiratory depression: a closed claims analysis. Anesthesiology 122:659\u2013665. https:\/\/doi.org\/10.1097\/ALN.0000000000000564","journal-title":"Anesthesiology"},{"key":"3563_CR56","doi-asserted-by":"publisher","first-page":"305","DOI":"10.5055\/jom.2015.0279","volume":"11","author":"T Lewis","year":"2015","unstructured":"Lewis T, Erfe BL, Ezell T et al (2015) Pharmacoepidemiology of opiate use in the neonatal ICU: Increasing cumulative doses and iatogenic opiate withdrawal. J Opioid Manag 11:305\u2013312. https:\/\/doi.org\/10.5055\/jom.2015.0279","journal-title":"J Opioid Manag"},{"key":"3563_CR57","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1177\/000992287501400613","volume":"14","author":"PJ Lipsitz","year":"1975","unstructured":"Lipsitz PJ (1975) A proposed narcotic withdrawal score for use with newborn infants: a pragmatic evaluation of its efficacy. Clin Pediatr (phila) 14:592\u2013594. https:\/\/doi.org\/10.1177\/000992287501400613","journal-title":"Clin Pediatr (phila)"},{"key":"3563_CR58","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/GRF.ObO13e31827feea4","volume":"56","author":"BA Logan","year":"2013","unstructured":"Logan BA, Brown MS, Hayes MJ (2013) Neonatal abstinence syndrome: treatment and pediatric outcomes. Clin Obstet Gynacol 56:186\u2013192. https:\/\/doi.org\/10.1097\/GRF.ObO13e31827feea4","journal-title":"Clin Obstet Gynacol"},{"key":"3563_CR59","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/J354v19n04_05","volume":"19","author":"RA Lugo","year":"2005","unstructured":"Lugo RA, Satterfield KL, Kern SE (2005) Pharmacokinetics of methadone. J Pain Palliat Care Pharmacother 19:13\u201324. https:\/\/doi.org\/10.1080\/J354v19n04_05","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"3563_CR60","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.cnc.2018.07.011","volume":"30","author":"NJ MacMullen","year":"2018","unstructured":"MacMullen NJ, Samson LF (2018) Neonatal abstinence syndrome: an uncontrollable epidemic. Crit Care Nurs Clin N Am 30:585\u2013596. https:\/\/doi.org\/10.1016\/j.cnc.2018.07.011","journal-title":"Crit Care Nurs Clin N Am"},{"key":"3563_CR61","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1055\/s-0037-1600917","volume":"34","author":"H Mactier","year":"2017","unstructured":"Mactier H, McLaughlin P, Gillis C et al (2017) Variations in infant CYP2B6 genotype associated with the need for pharmacological treatment for neonatal abstinence syndrome in infants of methadone-maintained opioid-dependent mothers. Am J Perinatol 34:918\u2013921. https:\/\/doi.org\/10.1055\/s-0037-1600917","journal-title":"Am J Perinatol"},{"key":"3563_CR62","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.drugalcdep.2009.12.016","volume":"108","author":"SD Mague","year":"2010","unstructured":"Mague SD (2010) Blendy JA (2010) OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models. Drug Alcohol Depend 108:172\u2013182. https:\/\/doi.org\/10.1016\/j.drugalcdep.2009.12.016","journal-title":"Drug Alcohol Depend"},{"key":"3563_CR63","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.siny.2019.01.009","volume":"24","author":"AK Mangat","year":"2019","unstructured":"Mangat AK, Schmolzer GM, Kraft WK (2019) Pharmacological and non-pharmacological treatments for the neonatal abstinence syndrome (NAS). Sem Fetal Neonatal Med 24:133\u2013141. https:\/\/doi.org\/10.1016\/j.siny.2019.01.009","journal-title":"Sem Fetal Neonatal Med"},{"key":"3563_CR64","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jpeds.2017.07.026","volume":"190","author":"P McLaughlin","year":"2017","unstructured":"McLaughlin P, Mactier H, Gillis C et al (2017) Increased DNA methylation of ABCB1, CYP2D6, and OPRM1 genes in newborn infants of methadone-maintained opioid-dependent mothers. J Pediatr 190:180-184.e1. https:\/\/doi.org\/10.1016\/j.jpeds.2017.07.026","journal-title":"J Pediatr"},{"key":"3563_CR65","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/jcph.1811","volume":"61","author":"BT McPhail","year":"2021","unstructured":"McPhail BT, Emoto C, Butler D et al (2021) Opioid treatment for neonatal opioid withdrawal syndrome: current challenges and future approaches. J Clin Pharmacol 61:857\u2013870. https:\/\/doi.org\/10.1002\/jcph.1811","journal-title":"J Clin Pharmacol"},{"key":"3563_CR66","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1056\/NEJMra1600879","volume":"375","author":"K McQueen","year":"2016","unstructured":"McQueen K, Murphy-Oikonen J (2016) Neonatal abstinence syndrome. New Engl J Med 375:2468\u20132479. https:\/\/doi.org\/10.1056\/NEJMra1600879","journal-title":"New Engl J Med"},{"key":"3563_CR67","doi-asserted-by":"publisher","first-page":"e067883","DOI":"10.1136\/bmjopen-2022-067883","volume":"13","author":"S Mills-Huffnagle","year":"2023","unstructured":"Mills-Huffnagle S, Nyland JE (2023) Potential problems and solutions of opioid-based treatment in neonatal opioid withdrawal syndrome (NOWS): a scoping review protocol. BMJ Open. 13:e067883. https:\/\/doi.org\/10.1136\/bmjopen-2022-067883","journal-title":"BMJ Open."},{"key":"3563_CR68","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1113\/jphysiol.2013.261974","volume":"592","author":"G Montandon","year":"2014","unstructured":"Montandon G, Horner R (2014) Cross talk proposal: the preB\u00f6tzinger complex is essential for the respiratory depression following systemic administration of opioid analgesics. J Physiol 592:1159\u20131162. https:\/\/doi.org\/10.1113\/jphysiol.2013.261974","journal-title":"J Physiol"},{"key":"3563_CR69","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1523\/JNEUROSCI.4611-10.2011","volume":"31","author":"G Montandon","year":"2011","unstructured":"Montandon G, Qin W, Liu H et al (2011) PreB\u00f6tzinger complex neurokinin-1 receptor-expressing neurons mediate opioid-induced respiratory depression. J Neurosci 31:1292\u20131301. https:\/\/doi.org\/10.1523\/JNEUROSCI.4611-10.2011","journal-title":"J Neurosci"},{"key":"3563_CR70","unstructured":"National Institute on Drug Abuse. Overdose Death Rates. January 20, 2022. https:\/\/nida.nih.gov\/drug-topics\/trends-statistics\/overdose-death-rates. Accessed 1 May, 2023."},{"key":"3563_CR71","doi-asserted-by":"publisher","first-page":"867","DOI":"10.2217\/pgs.1294","volume":"34","author":"DA Nielsen","year":"2009","unstructured":"Nielsen DA, Yuferov V, Hamon S et al (2009) Increased OPRM1 DNA methylation in lymphocytes of methadone-maintained former heroin addicts. Neuropsychopharmacology 34:867\u2013873. https:\/\/doi.org\/10.2217\/pgs.1294","journal-title":"Neuropsychopharmacology"},{"key":"3563_CR72","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.2217\/pgs.12.94","volume":"13","author":"DA Nielsen","year":"2012","unstructured":"Nielsen DA, Utrankar A, Reyes JA et al (2012) Epigenetics of drug abuse: predisposition or response. Pharmacogenomics 13:1149\u20131160. https:\/\/doi.org\/10.2217\/pgs.12.94","journal-title":"Pharmacogenomics"},{"key":"3563_CR73","unstructured":"NIH Heal Initiative Research Plan https:\/\/heal.nih.gov\/about\/research-plan. Accessed 29 April 2023"},{"issue":"5","key":"3563_CR74","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nrn3939","volume":"16","author":"DJ Nutt","year":"2015","unstructured":"Nutt DJ, Lingford-Hughes A, Erritzoe D et al (2015) (2015) The dopamine theory of addiction: 40 years of highs and lows. Nat Rev Neurosci 16(5):305\u2013312. https:\/\/doi.org\/10.1038\/nrn3939","journal-title":"Nat Rev Neurosci"},{"key":"3563_CR75","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1080\/09297049.2015.1092509","volume":"23","author":"E Nygaard","year":"2017","unstructured":"Nygaard E, Slinning K, Moe V et al (2017) Cognitive function of youths born to mothers with opioid and poly-substance abuse problems during pregnancy. Child Neuropsychol 23:159\u2013187. https:\/\/doi.org\/10.1080\/09297049.2015.1092509","journal-title":"Child Neuropsychol"},{"key":"3563_CR76","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ntt.2018.04.004","volume":"68","author":"E Nygaard","year":"2018","unstructured":"Nygaard E, Slinning K, Moe V et al (2018) Neuroanatomical characteristics of youths with prenatal opioid and poly-drug exposure. Neurotoxicol Teratol 68:13\u201326. https:\/\/doi.org\/10.1016\/j.ntt.2018.04.004","journal-title":"Neurotoxicol Teratol"},{"issue":"2","key":"3563_CR77","doi-asserted-by":"publisher","first-page":"e20162651","DOI":"10.1542\/peds.2016-2651","volume":"139","author":"JL Oei","year":"2017","unstructured":"Oei JL, Melhuish E, Uebel H et al (2017) Neonatal abstinence syndrome and high school performance. Pediatrics. 139(2):e20162651. https:\/\/doi.org\/10.1542\/peds.2016-2651","journal-title":"Pediatrics."},{"key":"3563_CR78","doi-asserted-by":"publisher","first-page":"9575","DOI":"10.1523\/jneurosci.23-29-09575,2003","volume":"23","author":"S Pagliardini","year":"2003","unstructured":"Pagliardini S, Ren J, Greer JJ et al (2003) Ontogeny of the pre-Botzinger complex in perinatal rats. J Neurosci 23:9575\u20139584. https:\/\/doi.org\/10.1523\/jneurosci.23-29-09575,2003","journal-title":"J Neurosci"},{"key":"3563_CR79","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3389\/fphar.2016.00514","volume":"7","author":"G Pang","year":"2016","unstructured":"Pang G, Wu X, Tao X et al (2016) Blockade of serotonin 5-HT2A receptors suppresses behavioral sensitization and naloxone-precipitated withdrawal symptoms in morphine-treated mice. Front Pharmacol 7:514. https:\/\/doi.org\/10.3389\/fphar.2016.00514","journal-title":"Front Pharmacol"},{"key":"3563_CR80","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/YPG.0000000000000095","volume":"25","author":"MA Patriquin","year":"2015","unstructured":"Patriquin MA, Bauer IE, Jair C et al (2015) Addiction pharmacogenetics: a systematic review of the genetic variation of the dopaminergic system. Psychiatr Genet 25:181\u2013193. https:\/\/doi.org\/10.1097\/YPG.0000000000000095","journal-title":"Psychiatr Genet"},{"key":"3563_CR81","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/bja\/aen094","volume":"100","author":"KTS Pattinson","year":"2008","unstructured":"Pattinson KTS (2008) Opioids and the control of respiration. Br J Anaesth 100:747\u2013758. https:\/\/doi.org\/10.1093\/bja\/aen094","journal-title":"Br J Anaesth"},{"key":"3563_CR82","doi-asserted-by":"publisher","first-page":"2230228","DOI":"10.1016\/j.drugalcdep.2012.01.013","volume":"124","author":"J Peng","year":"2012","unstructured":"Peng J, Sarkar S, Chang SL (2012) Opioid receptor expression in human brain and peripheral tissues using absolute quantitative real-time RT-PCR. Drug Alcohol Dependence 124:2230228. https:\/\/doi.org\/10.1016\/j.drugalcdep.2012.01.013","journal-title":"Drug Alcohol Dependence"},{"key":"3563_CR83","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1891\/0730-0832.38.3.160","volume":"38","author":"L Piccotti","year":"2019","unstructured":"Piccotti L, Voigtman B, Vongsa R et al (2019) Neonatal opioid withdrawal syndrome: a developmental care approach. Neonatal Netw 38:160\u2013169. https:\/\/doi.org\/10.1891\/0730-0832.38.3.160","journal-title":"Neonatal Netw"},{"key":"3563_CR84","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1177\/10600280221134643","volume":"57","author":"D Rana","year":"2023","unstructured":"Rana D, McLeod AR, Gaston PK et al (2023) Assessing neonatal opioid withdrawal syndrome severity as a function of maternal buprenorphine dose and umbilical cord tissue concentrations. Ann Pharmacother 57:892\u2013898. https:\/\/doi.org\/10.1177\/10600280221134643","journal-title":"Ann Pharmacother"},{"key":"3563_CR85","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/AOG.0000000000002054","volume":"130","author":"UM Reddy","year":"2017","unstructured":"Reddy UM, Davis JM, Ren Z et al (2017) Opioid use in pregnancy, neonatal abstinence syndrome, and childhood outcomes: executive summary of a joint workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American College of Obstetricians and Gynecologists, American Academy of Pediatrics, Society for Maternal-Fetal Medicine, Centers for Disease Control and Prevention, and the March of Dimes Foundation. Obstet Gynecol 130:10\u201328. https:\/\/doi.org\/10.1097\/AOG.0000000000002054","journal-title":"Obstet Gynecol"},{"key":"3563_CR86","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1542\/hpeds.2018-0227","volume":"9","author":"LA Sanlorenzo","year":"2019","unstructured":"Sanlorenzo LA, Cooper WO, Dudley JA et al (2019) Increased severity of neonatal abstinence syndrome associated with concomitant antenatal opioid and benzodiazepine exposure. Hosp Pediatr 9:569\u2013575. https:\/\/doi.org\/10.1542\/hpeds.2018-0227","journal-title":"Hosp Pediatr"},{"key":"3563_CR87","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.siny.2019.01.003","volume":"24","author":"DM Schiff","year":"2019","unstructured":"Schiff DM, Grossman MR (2019) Beyond the Finnegan scoring system: Novel assessment and diagnostic techniques for the opioid-exposed infant. Semin Fetal Neonatal Med 24:115\u2013120. https:\/\/doi.org\/10.1016\/j.siny.2019.01.003","journal-title":"Semin Fetal Neonatal Med"},{"key":"3563_CR88","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.earlhumdev.2017.01.009","volume":"106\u2013107","author":"E Sirnes","year":"2017","unstructured":"Sirnes E, Oltedal L, Bartsch H et al (2017) Brain morphology in school-aged children with prenatal opioid exposure: a structural MRI study. Early Hum Dev 106\u2013107:33\u201339. https:\/\/doi.org\/10.1016\/j.earlhumdev.2017.01.009","journal-title":"Early Hum Dev"},{"key":"3563_CR89","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1126\/science.1683005","volume":"254","author":"JC Smith","year":"1991","unstructured":"Smith JC, Ellenberger HH, Ballanyi K et al (1991) Pre-B\u00f6tzinger complex: a brainstem region that may generate respiratory rhythm in mammals. Science 254:726\u2013729. https:\/\/doi.org\/10.1126\/science.1683005","journal-title":"Science"},{"key":"3563_CR90","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1053\/j.semperi.2015.08.013","volume":"39","author":"MW Stover","year":"2015","unstructured":"Stover MW, Davis JM (2015) Opioids in pregnancy and neonatal abstinence syndrome. Semin Perinatol 39:561\u2013565. https:\/\/doi.org\/10.1053\/j.semperi.2015.08.013","journal-title":"Semin Perinatol"},{"key":"3563_CR91","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ogc.2014.02.010","volume":"41","author":"MB Sutter","year":"2014","unstructured":"Sutter MB, Leeman L, Hsi A (2014) Neonatal opioid withdrawal syndrome. Obstet Gynecol Clin North Am 41:317\u2013334. https:\/\/doi.org\/10.1016\/j.ogc.2014.02.010","journal-title":"Obstet Gynecol Clin North Am"},{"key":"3563_CR92","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0899-3289(20)30008-0","volume":"1","author":"RM Swift","year":"1989","unstructured":"Swift RM, Dudley M, DePetrillo P et al (1989) Altered methadone pharmacokinetics in pregnancy: implications for dosing. J Substance Abuse 1:453\u2013460. https:\/\/doi.org\/10.1016\/S0899-3289(20)30008-0","journal-title":"J Substance Abuse"},{"key":"3563_CR93","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nn.2104","volume":"11","author":"W Tan","year":"2008","unstructured":"Tan W, Janczewski WA, Yang P et al (2008) Silencing preBotzinger complex somatostatin-expressing neurons induces persistent apnea in awake rat. Nat Neurosci 11:538\u2013540. https:\/\/doi.org\/10.1038\/nn.2104","journal-title":"Nat Neurosci"},{"key":"3563_CR95","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.neuropharm.2013.06.016","volume":"76","author":"FM Vassoler","year":"2014","unstructured":"Vassoler FM, Byrnes EM, Pierce RC (2014) The impact of exposure to addictive drugs on future generations: physiological and behavioral effects. Neuropharmacology. 76:269\u2013275. https:\/\/doi.org\/10.1016\/j.neuropharm.2013.06.016","journal-title":"Neuropharmacology."},{"key":"3563_CR96","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.siny.2019.01.002","volume":"24","author":"EM Wachman","year":"2019","unstructured":"Wachman EM, Farrer LA (2019) The genetics and epigenetics of neonatal abstinence syndrome. Semin Fetal Neonatal Med 24:105\u2013110. https:\/\/doi.org\/10.1016\/j.siny.2019.01.002","journal-title":"Semin Fetal Neonatal Med"},{"key":"3563_CR97","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1001\/jama.2013.3411","volume":"309","author":"EM Wachman","year":"2013","unstructured":"Wachman EM, Hayes MJ, Brown MS et al (2013) Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome. JAMA 309:1821\u20131827. https:\/\/doi.org\/10.1001\/jama.2013.3411","journal-title":"JAMA"},{"key":"3563_CR98","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.jpeds.2014.05.040","volume":"165","author":"EM Wachman","year":"2014","unstructured":"Wachman EM, Hayes MJ, Lester BM et al (2014) Epigenetic variation in the mu-opioid receptor gene in infants with neonatal abstinence syndrome. J Pediatr 165:472\u2013478. https:\/\/doi.org\/10.1016\/j.jpeds.2014.05.040","journal-title":"J Pediatr"},{"key":"3563_CR99","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.drugalcdep.2015.07.001","volume":"155","author":"EM Wachman","year":"2015","unstructured":"Wachman EM, Hayes MJ, Sherva R et al (2015) Variations in opioid receptor genes in neonatal abstinence syndrome. Drug Alcohol Depend 155:253\u2013259. https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.07.001","journal-title":"Drug Alcohol Depend"},{"key":"3563_CR100","doi-asserted-by":"publisher","first-page":"e12476","DOI":"10.1111\/gbb.12476","volume":"17","author":"EM Wachman","year":"2018","unstructured":"Wachman EM, Hayes MJ, Shreatha J et al (2018) Epigenetic variation in OPRM1 gene in opioid-exposed mother-infant dyads. Genes Brain Behav. 17:e12476. https:\/\/doi.org\/10.1111\/gbb.12476","journal-title":"Genes Brain Behav."},{"key":"3563_CR101","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1001\/archpedi.1986.02140240061028","volume":"140","author":"SLD Ward","year":"1986","unstructured":"Ward SLD, Schuetz S, Krishna V et al (1986) Abnormal sleeping ventilatory pattern in infants of substance-abusing mothers. Am J Dis Child 140:1015\u20131020. https:\/\/doi.org\/10.1001\/archpedi.1986.02140240061028","journal-title":"Am J Dis Child"},{"key":"3563_CR102","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/s0022-3476(05)81896-81897","volume":"121","author":"SL Ward","year":"1992","unstructured":"Ward SL, Bautista DB, Woo MS et al (1992) Responses to hypoxia and hypercapnia in infants of substance-abusing mothers. J Pediatr 121:704\u2013709. https:\/\/doi.org\/10.1016\/s0022-3476(05)81896-81897","journal-title":"J Pediatr"},{"issue":"3","key":"3563_CR103","doi-asserted-by":"publisher","first-page":"a039669","DOI":"10.1101\/cshperspect.a039669","volume":"11","author":"AE Weller","year":"2021","unstructured":"Weller AE, Crist RC, Reiner BC et al (2021) Neonatal opioid withdrawal syndrome (NOWS): A transgenerational echo of the opioid crisis. Cold Spring Harb Perspect Med. 11(3):a039669. https:\/\/doi.org\/10.1101\/cshperspect.a039669","journal-title":"Cold Spring Harb Perspect Med."},{"key":"3563_CR104","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.jpeds.2014.05.010","volume":"165","author":"JR Wiles","year":"2014","unstructured":"Wiles JR, Isemann B, Ward LP et al (2014) Current management of neonatal abstinence syndrome secondary to intrauterine opioid exposure. J Pediatr 165:440\u2013446. https:\/\/doi.org\/10.1016\/j.jpeds.2014.05.010","journal-title":"J Pediatr"},{"key":"3563_CR105","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1542\/peds.63.1.135","volume":"63","author":"GS Wilson","year":"1979","unstructured":"Wilson GS, McCreary R, Kean J et al (1979) The development of preschool children of heroin-addicted mothers: a controlled study. Pediatrics 63:135\u2013141. https:\/\/doi.org\/10.1542\/peds.63.1.135","journal-title":"Pediatrics"},{"key":"3563_CR106","doi-asserted-by":"publisher","first-page":"e20173520","DOI":"10.1542\/peds.2017-3520","volume":"141","author":"TNA Winkelman","year":"2018","unstructured":"Winkelman TNA, Villapiano N, Kozhimannil KB et al (2018) Incidence and costs of neonatal abstinence syndrome among infants with Medicaid: 2004\u20132014. Pediatrics. 141:e20173520. https:\/\/doi.org\/10.1542\/peds.2017-3520","journal-title":"Pediatrics."},{"key":"3563_CR107","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1146\/annurev-psych-010418-103337","volume":"71","author":"RA Wise","year":"2020","unstructured":"Wise RA, Robbie MA (2020) Dopamine and addiction. Annu Rev Psychol 71:79\u2013106. https:\/\/doi.org\/10.1146\/annurev-psych-010418-103337","journal-title":"Annu Rev Psychol"},{"issue":"7","key":"3563_CR108","doi-asserted-by":"publisher","first-page":"e197025","DOI":"10.1001\/jamanetworkopen.2019.7025","volume":"2","author":"SL Yeoh","year":"2019","unstructured":"Yeoh SL, Eastwood J, Wright IM et al (2019) Cognitive and motor outcomes of children with prenatal opioid exposure: a systematic review and meta-analysis. JAMA Netw Open. 2(7):e197025. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.7025","journal-title":"JAMA Netw Open."},{"key":"3563_CR109","doi-asserted-by":"publisher","first-page":"e2020008839","DOI":"10.1542\/peds.2020-008839","volume":"147","author":"LW Young","year":"2021","unstructured":"Young LW, Hu Z, Annett RD et al (2021) Site-level variation in the characteristics and care of infants with neonatal opioid withdrawal. Pediatrics. 147:e2020008839. https:\/\/doi.org\/10.1542\/peds.2020-008839","journal-title":"Pediatrics."},{"key":"3563_CR110","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/jp.2014.111","volume":"34","author":"Q Yuan","year":"2014","unstructured":"Yuan Q, Rubic M, Seah J et al (2014) Do maternal opioids reduce neonatal regional brain volumes? A pilot study. J Perinatol 34:909\u2013913. https:\/\/doi.org\/10.1038\/jp.2014.111","journal-title":"J Perinatol"},{"key":"3563_CR111","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/00004703-199804000-00005","volume":"19","author":"W Zahorodny","year":"1998","unstructured":"Zahorodny W, Rom C, Whitney W (1998) The neonatal withdrawal inventory: a simplified score of newborn withdrawal. J Dev Behav Pediatr 19:89\u201393. https:\/\/doi.org\/10.1097\/00004703-199804000-00005","journal-title":"J Dev Behav Pediatr"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-023-03563-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-023-03563-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-023-03563-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T08:03:01Z","timestamp":1693641781000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-023-03563-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,3]]},"references-count":110,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["3563"],"URL":"https:\/\/doi.org\/10.1007\/s00204-023-03563-8","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,3]]},"assertion":[{"value":"9 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares no known competing financial interests or personal relationships that influenced the work reported here.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}